General Motors
BP
Ford Motor Company
AstraZeneca
DaimlerChrysler
CNN
General Electric
US Senate
Credit Suisse First Boston
Volkswagen
Siemens
Credit Lyonnais
Philip Morris
Bloomberg
Verizon
BBC
BP
AT&T
FIAT
Royal & SunAlliance
Nestle
General Dynamics
Hewlett Packard
ABN Amro
UBS Warburg
Merrill Lynch
New York Stock Exchange
The Economist
France Telecom
Boeing
Lafarge
AstraZeneca
AstraZeneca
Safeway
People's Republic of China's
AstraZeneca
Ministry of Agriculture
Nordea
Tesco
Pfizer
US State Department
Sun Microsystems
General Motors
Nestle
3
US Department of Defense
Philips
BP
Philips
Sybase
General Electric
Sprint
General Motors
New York Life Insurance
AT&T
Pfizer
Siemens
Lloyds
Canon USA
Novell
Ericsson
Nestle
EDS
Philip Morris International
Royal & SunAlliance
Novartis
Credit Lyonnais
Ericsson
Sun Microsystems
Britvic Softdrinks
Hewlett Packard
British American Tobacco
Sun Microsystems
Norsk Hydro
AstraZeneca
US State Department
Skanska
BAE Systems
Kodak
The Royal Mail Group
Henkel
Nestle
Bank of Montreal
Macmillan Publishing
Danske Bank
BMW
Kronos Corporation
New York Life Insurance
Fujitsu Technology Services
Zurich Financial Services
Halliburton
BBC
Blue Cross/Blue Shield of Massachusetts
T-Mobile
Channel 4 Corporation
BBC
VHA
Burges Salmon
AT&T
Motorola
British Telecom
Ferrari
ABN Amro
Swiss Army
Deloitte & Touche
PA Consulting
US Army
UK Department of Trade & Industry
Vodafone Omnitel
3
EMC Corporation
US Department of Commerce
Encana Corporation
IEEE
Hewitt Associates LLC
HEALTHvision
Paramount
Lexmark
Ericsson
US Department of Defense
JD Edwards
Ingersoll-Rand
PricewaterhouseCoopers
Vodafone Omnitel
3
Sun Microsystems
Nomura
Hewlett Packard
US State Department
Reed Elsevier
Dow Chemical Company
Siemens Power Generation
Texas Instruments
Forrester Research
McData
3
T-Mobile
US Department of Commerce
Wall Street Journal
Lloyds
NASA
SCA
Reuters
Danske Bank
AstraZeneca
ITN
Lloyds
Siemens
IBM NICA
Philips
Forbes.com
Nissan North America, Inc.
Toyota Motor
Philips
The McGraw-Hill Companies
Fox Sports
AstraZeneca
Society of Petroleum Engineers
US Department of Defense
US Department of Energy
US State Department
European Commission
Telecom Italia
Harrah's
AXA
BP
UK Department of Trade & Industry
Sybase
Napster
Nestle
Oracle
Lloyds
Compuware
Olympus
MOL
ARM
Taylor & Francis
Federal Express
The McGraw-Hill Companies
General Motors
Nissan Motor
Milward Brown Precis
Federal Government of Canada
AstraZeneca
UK Home Office
HM Revenue & Customs
3
Harvard Business School
Britvic Softdrinks
MOL
Macmillan Publishing
Allianz Life Insurance Co
Swiss Army
UK Department of Trade & Industry
General Motors
Parliament of Singapore
VMS
Singapore Police Force
Sony Music
GSA Advantage!
Kaiser Permanente
Ingersoll-Rand
Stanford Business School
Johns Hopkins
Wachovia
Standard Life Insurance
Raytheon
Commerzbank
Allstate Insurance
State of Washington
Napa Valley County
3
Texas Department of Transportation
Philips
American HomePatient
TIBCO
Sharper Image
HM Revenue & Customs
Henkel
Xerox
America Online
Lockheed Northrop Grumman
Dow Chemical Company
Draeger Medical
Sutter Health
Kenyan AIDS Clinic
University of Washington
3
State of Minnesota
World Wildlife Fund
Autonomy Group Customers
 
News
Events
RSS Feeds
Press Release Archives
For Financial News, please see the Investors section of the website.

News CARDIFF OFFERS FIRST... | NATIVEMINDS AND GLAX... | VERITY NAMES CHARU R...
Press Release
Related Events
Related Case Studies
Related Resources

NativeMinds and GlaxoSmithKline Help Smokers Kick the Habit Online with New Virtual Representative

GlaxoSmithKline Introduces vRep, Nick, on Three Web Sites to Answer Frequently Asked Questions 24/7

San Francisco, CA - 2000-11-13 - As smokers across the country resolve to quit smoking this week for the American Cancer Society's Great American Smokeout, GlaxoSmithKline Consumer Healthcare (SBCH) is preparing to launch its new virtual representative (vRepTM) that will be introduced on three Web sites including www.nicorette.com, www.nicoderm.com and www.committedquitters.com on Thursday, November 16. NativeMinds, Inc., a leading provider of automated, natural-language customer service representatives for the Internet, is enabling GlaxoSmithKline to create an automated online personality to help people quickly navigate their site and obtain the information they need about quitting smoking and two of the best products to help them become smoke-free. The new vRep, Nick, will be available 24 hours a day, seven days a week to immediately answer the most frequently asked questions about the NicoDerm® CQ® patch and Nicorette® gum products, as well as offer tips on how to quit smoking.

GlaxoSmithKline's vRep initiative is designed to create an engaging and more productive Web experience by humanizing the way people get information. Online customer service and personalized self-help are emerging as strategic e-business imperatives as companies rush to upgrade online service quality and strengthen customer loyalty. GlaxoSmithKline is launching Nick in time for the Great American Smokeout, an event during which a portion of the estimated 50 million smokers in the United States make a quit attempt. Nick will be able to provide fast answers to common questions so that live customer service representatives can be freed up to answer more critical or complex questions.

"When people make the decision to quit smoking, many of them turn to our smoking cessation products and clinically proven behavioral support programs to help begin the process," said Ed Lara, director of marketing, smoking control for GlaxoSmithKline's NicoDerm CQ brand. "Those on the verge of giving in to a craving do not have the time or energy to be sifting through Web pages trying to find specific information. Nick will not only be able to respond to these serious quitters' questions but also pushes the correct Web pages and provides a friendly human interface that puts visitors at ease."

Nick was created by NativeMinds in only five weeks and is the first vRep to appear on a consumer healthcare site. To extend its offline branding efforts online, Smith Kline Beecham designed Nick's graphical interface based on a cartoon character that first appeared as a helpful guide in the print version of the Nicorette users guide. The company will take further advantage of the interactive medium by continually adding content to Nick via NativeMinds' easy-to-use contributor interface and by having Nick appear in different clothing and backgrounds depending on the holiday or season.

"With the wealth of information available on GlaxoSmithKline's three consumer Web sites, the company is ensuring its customers find the information they need in a quick and intuitive manner," said Walter Tackett, CEO and co-founder of NativeMinds. "NativeMinds' vRep technology allows users to zero in on the most relevant information by asking questions in plain English and receiving immediate responses in the same, user-friendly format. Nick not only reduces the number of costly call center inquiries, but also provides online businesses with a conversational, human-like customer support interface to ensure customer satisfaction."

About NativeMinds

Incorporated in 1999, NativeMinds is the leading provider of software and services to create automated natural-language customer service and sales representatives - vReps - for eCRM. Leading customers of NativeMinds' vRep solutions include Oracle, Convergys, One 2 One, Axcess.com, reflect.com, and GlaxoSmithKline. NativeMinds is a privately held corporation based in San Francisco, CA. For more information, visit www.nativeminds.com.

For more information, contact Verity at info@verity.com or at World Wide Web site http://www.verity.com or call 408-541-1500.

Verity and the Verity logo are registered trademarks or trademarks of Verity, Inc.

Geneviève Peterson

NativeMinds, Inc.

(415) 777 3111

gpeterson@neuromedia.com

Vanessa Gaw

A&R Partners

(650) 762 2820

vgaw@arpartners.com

There do not seem to be any upcoming events related to this page at the moment, please visit our seminar and webinar pages for more information.

This is a small selection of the Autonomy case studies available, please visit our publications site at http://publications.autonomy.com/ for more information.

Automatic Hyperlinks provided by IDOL Server 7

+1 415 243 9955

Company
Technology
Functionality
Products
Solutions
Services
Customers
Partners
News & Events